Preclinical and Clinical Advances of GalNAc-Decorated Nucleic Acid Therapeutics
Author:
Funder
National Natural Science Foundation of China
Postdoctoral Science Foundation of China
Beijing Institute of Technology
Publisher
Elsevier BV
Subject
Drug Discovery,Molecular Medicine
Reference123 articles.
1. RNAi therapeutics: a potential new class of pharmaceutical drugs;Bumcrot;Nat. Chem. Biol.,2006
2. RNAi and small interfering RNAs in human disease therapeutic applications;Lares;Trends Biotechnol.,2010
3. Safety and efficacy of RNAi therapy for transthyretin amyloidosis;Coelho;N. Engl. J. Med.,2013
4. Retrospective study of a TTR FAP cohort to modify NIS+7 for therapeutic trials;Suanprasert;J. Neurol. Sci.,2014
5. Toxicological and pharmacokinetic properties of QPI-1007, a chemically modified synthetic siRNA targeting caspase 2 mRNA, following intravitreal injection;Solano;Nucleic Acid Ther.,2014
Cited by 233 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Advances in nucleic acid therapeutics: structures, delivery systems, and future perspectives in cancer treatment;Clinical and Experimental Medicine;2024-08-28
2. Advances in MicroRNA Therapeutics: from Preclinical to Clinical Studies;Human Gene Therapy;2024-08-16
3. A therapeutic approach for the hepatitis C virus: in silico design of an antisense oligonucleotide-based candidate capsid inhibitor;Virus Genes;2024-07-31
4. Lipid-nanoparticle-enabled nucleic acid therapeutics for liver disorders;ACTA PHARM SIN B;2024
5. Lipid-nanoparticle-enabled nucleic acid therapeutics for liver disorders;Acta Pharmaceutica Sinica B;2024-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3